ARCHIVES

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Colorectal Cancer Progress Review Group To Assess Research

October 1, 1999

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87

March 6, 1987

Bristol-Myers, IVAX submit Competing Application for Paclitaxel Use In KS

April 18, 1997

Excerpts Presented From Pepper Hearing

July 20, 1979

NCI’s Plan to Limit Growth of Core Grants Prompts Smaller Cancer Centers to Cry Foul

May 11, 2012